HealthTech Valuation Multiples

Explore the DealMatrix Industry Multiple for HealthTech: EV/Sales and EV/EBITDA across all regions.

Coverage
EV/Sales; EV/EBITDA
Valuation Multiples
Private Market
Benchmarks
All Regions
Industry Multiple
Quarterly
Updated

HealthTech

HealthTech companies digitise care delivery, diagnostics, and patient engagement with software and connected devices. Private-market valuations reflect clinical validation, payer or provider distribution, and the share of recurring, reimbursable revenue.

The category spans digital therapeutics, care-delivery platforms, remote monitoring, and health data infrastructure.

Key Drivers
→
Clinical Validation
Evidence of outcomes unlocks reimbursement, trust, and durable adoption.
→
Payer & Provider Distribution
Access to payer and provider channels is the gate to scalable revenue.
→
Recurring & Reimbursable Revenue
Recurring, reimbursed revenue is valued well above one-off service fees.
→
Regulatory & Data Compliance
A clean regulatory and data-privacy posture de-risks scale.

Sector

HealthTech

Health & Life Sciences

Sector tracked since

2000

25+ years of data

EV/SALES & EV/EBITDA FOR

All Regions

Modelled independently via proprietary econometric approach

UPDATE FREQUENCY

Quarterly

Data updates & model improvement

HealthTech Valuation Multiples

DealMatrix Industry Multiple, HealthTech, All Regions
EV/Sales 5.1×EV/EBITDA 23.4×as of 31 Dec 2025

Derived from listed-company data through the DealMatrix model and industry mapping, before stage adjustment.

A Series A HealthTech company in Europe is priced differently. Get the DealMatrix Multiple for your stage and region.

Run HealthTech for your stage and region →

The Venionaire DealMatrix Multiples Model

DealMatrix multiples are proprietary private-market benchmarks, derived through a six-step model that translates public capital-market index comparables into private-market segments and funding stages, adjusted for macroeconomic conditions.

The model produces three components: The reported public multiple, the model-predicted multiple, and the lower bound predicted multiple averaged into the DealMatrix Composite, then adjusted for region and funding stage. The methodology follows the IPEV Guidelines 2025.

Model Architecture
01
Data Acquisition
200 Public Indices
02
Statistical Cleaning
Outliers & Gaps
03
Econometric Modelling
Macro & Averaging
04
Regional Adjustment
6 Regions
05
Industry Weighting
150 Categories
06
Stage Adjustment
Pre-Seed → Series E
Final DealMatrix Multiple
EV/Sales and EV/EBITDA by sector, region and stage
Following IPEV Guidelines 2025, updated each quarter
Latest HealthTech Deals

Similar industries to explore

Valuation benchmarks differ across industries as business models, growth rates and margins vary. Explore the sectors most related to HealthTech to see how their EV/Sales and EV/EBITDA multiples compare.

HealthTech Valuation Multiples — FAQ

What is the valuation multiple for HealthTech companies?

As of 31 December 2025, the DealMatrix Industry Multiple for HealthTech across all regions is 5.1× EV/Sales and 23.4× EV/EBITDA. It is derived from listed-company data through the DealMatrix model and industry mapping, before stage adjustment.

Why does a HealthTech company at my stage or in my region get a different multiple?

The industry multiple covers all regions and is shown before stage adjustment. A Series A HealthTech company in Europe is priced differently. The DealMatrix platform gives the multiple for your stage and region.

What is the difference between EV/Sales and EV/EBITDA for HealthTech?

EV/Sales (enterprise value ÷ revenue) is used for high-growth HealthTech companies that are not yet profitable, while EV/EBITDA (enterprise value ÷ operating profit) applies to mature, profitable ones. Early-stage companies are usually benchmarked on EV/Sales.

How is the HealthTech industry multiple calculated?

It is derived from listed-company data through the DealMatrix model and industry mapping. The methodology follows the IPEV Guidelines 2025.

How current is this HealthTech figure?

The figure shown is as of 31 December 2025. Current-quarter figures are available in the DealMatrix platform.

Start using data-driven private equity/venture capital multiples.